Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Colletti

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
The Journal of Pharmacology and Experimental Therapeutics|August 8, 2012
Deletion of Abcg2 has differential effects on excretion and pharmacokinetics of probe substrates in ratsLiyue Huang, Xuhai Be, Eskouhie H Tchaparian, et al.
The American Journal of Emergency Medicine|January 30, 2026
Artificial intelligence in emergency medicine: a narrative reviewAngelica Rego, Juan Pablo Arango-Ibanez, R Andrew Taylor, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 9, 1997
Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogsK L Thompson, S H Vincent, R R Miller, et al.
Scientific Reports|July 1, 2017
nr3c1 null mutant zebrafish are viable and reveal DNA-binding-independent activities of the glucocorticoid receptorN Facchinello, T Skobo, G Meneghetti, et al.
Scientific Reports|March 10, 2018
Author Correction: nr3c1 null mutant zebrafish are viable and reveal DNA-binding-independent activities of the glucocorticoid receptorN Facchinello, T Skobo, G Meneghetti, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 1, 1996
Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeysS H Vincent, S K Painter, P A Krieter, et al.
Journal of Medicinal Chemistry|October 16, 1992
Highly potent, orally active diester macrocyclic human renin inhibitorsA E Weber, M G Steiner, P A Krieter, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 18, 2002
The pharmacokinetics of a thiazole benzenesulfonamide beta 3-adrenergic receptor agonist and its analogs in rats, dogs, and monkeys: improving oral bioavailabilityRalph A Stearns, Randy R Miller, Wei Tang, et al.
Bioorganic & Medicinal Chemistry Letters|March 8, 2011
Discovery of triazine-benzimidazoles as selective inhibitors of mTOREmily A Peterson, Paul S Andrews, Xuhai Be, et al.
Bioorganic & Medicinal Chemistry Letters|July 7, 2012
Discovery and optimization of potent and selective imidazopyridine and imidazopyridazine mTOR inhibitorsEmily A Peterson, Alessandro A Boezio, Paul S Andrews, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
The Journal of Pharmacology and Experimental Therapeutics|August 8, 2012
Deletion of Abcg2 has differential effects on excretion and pharmacokinetics of probe substrates in ratsLiyue Huang, Xuhai Be, Eskouhie H Tchaparian, et al.
The American Journal of Emergency Medicine|January 30, 2026
Artificial intelligence in emergency medicine: a narrative reviewAngelica Rego, Juan Pablo Arango-Ibanez, R Andrew Taylor, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 9, 1997
Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogsK L Thompson, S H Vincent, R R Miller, et al.
Scientific Reports|July 1, 2017
nr3c1 null mutant zebrafish are viable and reveal DNA-binding-independent activities of the glucocorticoid receptorN Facchinello, T Skobo, G Meneghetti, et al.
Scientific Reports|March 10, 2018
Author Correction: nr3c1 null mutant zebrafish are viable and reveal DNA-binding-independent activities of the glucocorticoid receptorN Facchinello, T Skobo, G Meneghetti, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 1, 1996
Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeysS H Vincent, S K Painter, P A Krieter, et al.
Journal of Medicinal Chemistry|October 16, 1992
Highly potent, orally active diester macrocyclic human renin inhibitorsA E Weber, M G Steiner, P A Krieter, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 18, 2002
The pharmacokinetics of a thiazole benzenesulfonamide beta 3-adrenergic receptor agonist and its analogs in rats, dogs, and monkeys: improving oral bioavailabilityRalph A Stearns, Randy R Miller, Wei Tang, et al.
Bioorganic & Medicinal Chemistry Letters|March 8, 2011
Discovery of triazine-benzimidazoles as selective inhibitors of mTOREmily A Peterson, Paul S Andrews, Xuhai Be, et al.
Bioorganic & Medicinal Chemistry Letters|July 7, 2012
Discovery and optimization of potent and selective imidazopyridine and imidazopyridazine mTOR inhibitorsEmily A Peterson, Alessandro A Boezio, Paul S Andrews, et al.
Pageof 4